Pretreatment with periodate-oxidized adenosine enhances developmental toxicity of inorganic arsenic in mice

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 68, Issue 4, 2003, Pages 335-343

  Lammon, Carol A ^a   Le, X Chris ^b   Hood, Ronald D ^c,d  

^a UNIVERSITY OF ALABAMA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Ronald D Hood and Associates   (United States)

^d UNIVERSITY OF ALABAMA   (United States)

Author keywords

Arsenate; Arsenic; Arsenite; Developmental toxicity; Methylation; Mice; Periodate oxidized adenosine

Indexed keywords

ADENOSINE; ARSENATE SODIUM; ARSENIC; ARSENITE SODIUM; PERIODATE;

ANIMAL MODEL; ARTICLE; BONE MALFORMATION; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FETUS WEIGHT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCIDENCE; METHYLATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TOXICITY;

ABNORMALITIES, DRUG-INDUCED; ADENOSINE; ANIMALS; ARSENATES; ARSENITES; BODY WEIGHT; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; MALE; METHYLATION; MICE; MUSCLE, SKELETAL; PREGNANCY; PREGNANCY, ANIMAL; SODIUM COMPOUNDS; TERATOGENS;

ANIMALIA; MAMMALIA;

EID: 0141890085     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.10029     Document Type: Article

References (69)

1. Aposhian VH, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM. 2000. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693-697.
2. Baxley MN, Hood RD, Vedel GC, Harrison WP, Szczech GM. 1981. Prenatal toxicity of orally administered sodium arsenite in mice. Bull Environ Contam Toxicol 26:749-756.
3. Beaudoin AR. 1974. Teratogenicity of sodium arsenate in rats. Teratology 10:153-158.
4. Bollinger CT, Van Zijl P, Louw JA. 1992. Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. Respiration 59:57-61.
5. Buchet JP, Lauwerys R, Roels H. 1981a. Comparison of urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsenate in man. Int Arch Occup Environ Health 48:71-79.
6. Buchet JP, Lauwerys R, Roels H. 1981b. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium meta arsenite by volunteers. Int Arch Occup Environ Health 48:111-118.
7. Burk D, Beaudoin AR. 1977. Arsenate-induced renal agenesis in rats. Teratology 16:247-260.
8. Concha G, Vogler G, Nermell B, Vahter M, 1998a. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect 106:355-359.
9. Concha G, Vogler G, Lezeano D, Nermell B, Vahter M. 1998b. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44:185-190.
10. Concha GG, Vogler G, Nermell B, Vahter M. 1998c. Low arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. Int Arch Occup Environ Health 71:42-46.
11. Crary DD. 1962. Modified benzyl alcohol clearing of alizarin stained specimens without loss of flexibility. Stain Technol 37:124-125.
12. Daniel W. 1995. Biostatistics: A foundation for analysis in the health sciences. 6th Ed. New York: John Wiley and Sons, 780 p.
13. Daya MR, Irwin R, Parshley MC, Harding J, Burton BT. 1989. Arsenic ingestion in pregnancy. Vet Hum Toxicol 31:347.
14. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. 2001. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 174:282-293.
15. DeSesso JM, Jacobson CF, Scialli AR, Farr CH, Holson JE 1998. An assessment of the developmental toxicology of inorganic arsenic. Reprod Toxicol 12:385-433.
16. Feldmann J, Lai V W-M, Cullen, WR, Ma M, Lu X, Le XC. 1999. Sample preparation and storage can change arsenic speciation in human urine. Clin Chem 45:1988-1997.
17. Ferm VH, Carpenter S. 1968. Malformations induced by sodium arsenate. J Reprod Fertil 17:199-201.
18. Fowler B. 1977. Environmental arsenic toxicology. In: Carnow RW, editor. Health effects of occupational lead and arsenic exposure: a symposium held in Chicago. DHEW pub (NIOSH) 76-134, GPO. February 24-25, 1975.
19. Gerber GB, Maes J, Eykens B. 1982. Transfer of antimony and arsenic to the developing organism. Arch Toxicol 49:159-168.
20. Guo X, Fujino Y, Kaneko S, Wu K, Xia Y, Yoshimura T. 2001. Arsenic contamination of groundwater and prevalence of arsenical dermatosis in the Hetao plain area, Inner Mongolia, China. Mol Cell Biochem 222:137-140.
21. Hanlon DP, Ferm VH. 1977. Placental permeability of arsenate ion during early embryogenesis in the hamster. Experientia 33:1221-1222.
22. Harrison WP, Frazier JC, Mazzanti EM, Hood RD. 1980. Teratogenicity of disodium methane arsonate and sodium dimethylarsenate (sodium cacodylate) in mice. Teratology 21:43A.
23. Hoffman DR, Cornatzer WE, Duerre JA. 1979. Relationship between tissue levels of s-adenosylmethionine, s-adenosylhomocysteine and transmethylation reaction. Can J Biochem 57:56-65.
24. Hoffman J. 1980. The rate of transmethylation in mouse liver as measured by trapping s-adenosylhomocysteine, Arch Biochem Biophys 205:132-135.
25. Holson JF, Stump DG, Knapp KJ, Farr CH. 2000. Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem Toxicol 38:459-466.
26. Holson JF, Stump DG, Ulrich CE, Farr CH. 1999. Absence of prenatal developmental toxicity from inhaled arsenic trioxide in rats. Toxicol Sci 51:87-97.
27. Hood RD. 1972. Effects of sodium arsenite on fetal development. Bull Environ Contam Toxicol 7:216-222.
28. Hood RD, Bishop SL. 1972. Teratogenic effects of sodium arsenate in mice. Arch Environ Health 24:62-65.
29. Hood RD, Harrison WP. 1982. Effects of prenatal arsenite exposure in the hamster. Bull Environ Contam Toxicol 29:671-678.
30. Hood RD, Thacker GT, Patterson BL, Szczech GM. 1978. Prenatal effects of oral versus intraperitoneal sodium arsenate in mice. J Environ Pathol Toxicol 1:857-864.
31. Hood RD, Vedel-Macrander GC, Zaworotko MJ, Tatum FM, Meeks GR. 1987. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology 35:19-25.
32. Hood RD, Vedel GC, Zaworotko MJ, Tatum FM. 1988. Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse. J Toxicol Environ Health 25:423-434.
33. Hughes MF. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133:1-16.
34. Hunter ES III. 2000. Role of oxidative damage in arsenic-induced teratogenesis. Teratology 62:240.
35. Kantor HI, Levin PM. 1948. Arsenical encephalopathy in pregnancy with recovery. Am J Obstet Gynecol 56:370-374.
36. Le XC, Lu X, Ma M, Cullen WR, Aposhian V, Zheng B. 2000. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem 72:5172-5177.
37. Le XC, Ma M. 1998. Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal Chem 70:1926-1933.
38. Lehninger AL, Nelson DL, Cox MM, editors. 1993. Principles of biochemistry, 2nd ed. New York: Worth Publishers.
39. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ. 2002. A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795-10803.
40. Lindau L. 1977. Emissions of arsenic in Sweden and their reduction. Environ Health Perspect 19:25-29.
41. Lindgren A, Danielsson BRG, Dencker L, Vahter M. 1984. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol 54:311-320.
42. Liu J, Zheng B, Aposhian HV, Zhou Y, Chen M-L, Zhang A, Waalkes MP. 2002. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environ Health Perspect 110:119-122.
43. Lugo G, Cassady G, Palmissano P. 1969. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child 117:328-330.
44. 74 As arsenite in mice and rabbits. Chem Biol Interact 50:49-57.
45. Marafante E, Vahter M, Envall J. 1985. The role of methylation in the detoxification of arsenate in the rabbit. Chem Biol Interact 56:225-238.
46. Matsumoto, N. 1973. Effects of Na-arsenate on the growth and development of the foetal mice. Teratology 8:98.
47. McKinney JD. 1992. Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health 14:43-48.
48. Morrissey RE, Mottet NK. 1983. Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology 28:399-411.
49. Muñoz O, Diaz OP, Leyton I, Nuñez N, Devesa V, Súñer A, Vélez D, Montoro R. 2002. Vegetables collected in the cultivated Andean area of Northern Chile: total and inorganic arsenic contents in raw vegetables. J Agric Food Chem 50:642-647.
50. Nelson KW. 1977. Industrial contributions of arsenic to the environment. Environ Health Perspect 19:31-34.
51. Nemec MD, Holson JF, Farr CH, Hood RD. 1998. Developmental toxicity assessment of arsenic acid in mice and rabbits. Reprod Toxicol 12:647-658.
52. Okoji RS, Yu RC, Maronpot RR, Froines JR. 2002. Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis 23:777-785.
53. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol 14:651-656.
54. Shivapurkar N, Poirer A. 1983. Tissue levels of s-adenosylhomocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks. Carcinogenesis 4:1051-1057.
55. Stump DG, Holson JF, Fleeman TL, Nemec MD, Farr CH. 1999. Comparative effects of single i.p. or oral doses of sodium arsenate or arsenic trioxide during in utero development. Teratology 60:283-291.
56. Thomas DJ, Styblo M, Lin S. 2001. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176:127-144.
57. Vahter M. 1983. Metabolism of arsenic. In: Fowler BA, editors. Biological and environmental effects of arsenic. Amsterdam: Elsevier. p 171-198.
58. Vahter M. 1994. Species differences in the metabolism of arsenic compounds. Appl Organomet Chem 8:175-182.
59. Vahter M. 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112:209-217.
60. Vahter M, Concha G. 2001. Role of metabolism in arsenic toxicity. Pharmacol Toxicol 89:1-5.
61. Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. 1995. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol 293:455-462.
62. Vahter M, Marafante E. 1987. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37:41-46.
63. 74As-dimethylarsinic acid in mice and rats. Arch Environ Contam Toxicol 13:259-264.
64. Walsh LM, Sumner ME, Keeney DR. 1977. Occurrence and distribution of arsenic in soils and plants. Environ Health Perspect 19:67-71.
65. Watanabe C. 2001. Environmental arsenic exposure in Bangladesh: water versus extra-water intake of arsenic. Environ Sci 8:459-466.
66. Watanabe T, Endo A. 1988. Digit development and embryonic weight in mice: analysis of sex-related time difference and mating period-related interlitter variability. Teratology 38:157-163.
67. Webb GN, Byrd RA. 1994. Simultaneous differential staining of cartilage and bone in rodent fetuses: an Alcian blue and alizarin red S procedure without glacial acetic acid. Biotech Histochem 69:181-185.
68. Whanger PD, Weswig PH, Stoner JC. 1977. Arsenic levels Oregon waters. Environ Health Perspect 19:139-143.
69. Wlodarczyk B, Bennett GD, Calvin JA, Craig JC, Finnell RH. 1996. Arsenic-induced alterations in embryonic transcription factor gene expression: Implications for abnormal neural development. Dev Genet 18:306-315.